Tags

Type your tag names separated by a space and hit enter

The American Heart Association science advisory on depression and coronary heart disease: an exploration of the issues raised.
Cleve Clin J Med 2010; 77 Suppl 3:S12-9CC

Abstract

The American Heart Association issued a science advisory on depression and coronary heart disease (CHD) in 2008. This paper reviews the purpose and content of the advisory and discusses reactions and new information that have followed the advisory's release. Both the advisory and subsequent data support routine screening for depression in patients with CHD. Such screening can be done efficiently in primary care and cardiology settings and can effectively identify many depressed patients who would otherwise go undetected. Antidepressant drugs such as selective serotonin reuptake inhibitors are safe for use in patients with CHD, can reduce depression, and can improve adherence with medical therapy. Referral to a practice with the knowledge and resources to manage depression promotes successful management of depressed patients with CHD.

Authors+Show Affiliations

Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA. Jtb2@columbia.eduNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20622070

Citation

Bigger, J Thomas, and Alexander H. Glassman. "The American Heart Association Science Advisory On Depression and Coronary Heart Disease: an Exploration of the Issues Raised." Cleveland Clinic Journal of Medicine, vol. 77 Suppl 3, 2010, pp. S12-9.
Bigger JT, Glassman AH. The American Heart Association science advisory on depression and coronary heart disease: an exploration of the issues raised. Cleve Clin J Med. 2010;77 Suppl 3:S12-9.
Bigger, J. T., & Glassman, A. H. (2010). The American Heart Association science advisory on depression and coronary heart disease: an exploration of the issues raised. Cleveland Clinic Journal of Medicine, 77 Suppl 3, pp. S12-9. doi:10.3949/ccjm.77.s3.03.
Bigger JT, Glassman AH. The American Heart Association Science Advisory On Depression and Coronary Heart Disease: an Exploration of the Issues Raised. Cleve Clin J Med. 2010;77 Suppl 3:S12-9. PubMed PMID: 20622070.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The American Heart Association science advisory on depression and coronary heart disease: an exploration of the issues raised. AU - Bigger,J Thomas, AU - Glassman,Alexander H, PY - 2010/7/13/entrez PY - 2010/8/7/pubmed PY - 2010/11/16/medline SP - S12 EP - 9 JF - Cleveland Clinic journal of medicine JO - Cleve Clin J Med VL - 77 Suppl 3 N2 - The American Heart Association issued a science advisory on depression and coronary heart disease (CHD) in 2008. This paper reviews the purpose and content of the advisory and discusses reactions and new information that have followed the advisory's release. Both the advisory and subsequent data support routine screening for depression in patients with CHD. Such screening can be done efficiently in primary care and cardiology settings and can effectively identify many depressed patients who would otherwise go undetected. Antidepressant drugs such as selective serotonin reuptake inhibitors are safe for use in patients with CHD, can reduce depression, and can improve adherence with medical therapy. Referral to a practice with the knowledge and resources to manage depression promotes successful management of depressed patients with CHD. SN - 1939-2869 UR - https://www.unboundmedicine.com/medline/citation/20622070/The_American_Heart_Association_science_advisory_on_depression_and_coronary_heart_disease:_an_exploration_of_the_issues_raised_ L2 - http://www.diseaseinfosearch.org/result/130 DB - PRIME DP - Unbound Medicine ER -